- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
2008.
-
- Oct.17.2008
- Ono Enters into License Agreement with Progenics(81 KB)
-
- Oct.01.2008
- Announcement on Results of Phase II / III Clinical Study in Japan with Arocyte for Injection for Treatment of Acute Ischemic Stroke(50 KB)
-
- Sep.22.2008
- Announcement on Completion of Acquisition of the Company's Own Shares(86 KB)
-
- Aug.05.2008
- Revisions of First Half / Full Year Business Forecasts for FY 2008(73 KB)
-
- Aug.05.2008
- Announcement on Changes of Representative Directors and Members of the Board of Directors(121 KB)
-
- Jun.03.2008
- Preliminary Data from Ongoing Phase 1 Trial of Investigational Fully Human Anti-PD-1 Antibody “ONO-4538/MDX-1106” Presented at American Society of Clinical Oncology(106 KB)
-
- May.14.2008
- Announcement on Changes of Representative Directors and Members of the Board of Directors(114 KB)
-
- May.14.2008
- Announcement on Partial Amendments to the Articles of Incorporation(66 KB)
-
- May.08.2008
- Ono Resolved Increase in Dividends Projected for Fiscal 2007(the 60th Fiscal Term ending on March 31, 2008)(129 KB)
-
- Apr.17.2008
- Discontinuation of Development for an Additional Indication of Cervical Spondylosis of Limaprost Alfadex,an Oral Prostaglandin E1 Derivative Preparation(54 KB)
-
- Apr.14.2008
- Functionality Expansion of Ono Pharma USA, Inc., which is Ono's US Development Base(58 KB)
-
- Apr.14.2008
- Announcement on Acquisition of the Company's Own Shares(61 KB)
-
- Mar.27.2008
- Ono Enters into New Fragment-Based Drug Discovery Agreement on a Protease Target with Evotec AG(67 KB)